Structural and functional characterization of the trifunctional antibody catumaxomab

References

• Lindhofer H. Trifunctional antibody format: Concept and first drug candidate. Pharma Focus Asia 2008; 9:51 - 54
   Google Scholar
• Chames P, Baty D. Bispecific antibodies for cancer therapy: the light at the end of the tunnel?. MAbs 2009; 1:1 - 9
   Google Scholar
• Zeidler R, Reisbach G, Wollenberg B, Lang S, Chaubal S, Schmitt B, et al. Simultaneous activation of T cells and accessory cells by a new class of intact bispecific antibody results in efficient tumor cell killing. J Immunol 1999; 163:1246 - 1252
   PubMed Web of Science ®Google Scholar
• Zeidler R, Mysliwietz J, Csánady M, Walz A, Ziegler I, Schmitt B, et al. The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer 2000; 83:261 - 266
   PubMed Web of Science ®Google Scholar
• Ruf P, Lindhofer H. Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody. Blood 2001; 98:2526 - 2534
   PubMed Web of Science ®Google Scholar
• Franki SN, Steward KK, Betting DJ, Kafi K, Yamada RE, Timmerman JM. Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. Blood 2008; 111:1504 - 1511
   PubMed Web of Science ®Google Scholar
• Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 2000; 6:443 - 446
   PubMed Web of Science ®Google Scholar
• Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, et al. High resolution mapping of the binding site on human IgG1 for FcgammaRI, FcgammaRII, FcgammaRIII and FcRn and design of IgG1 variants with improved binding to the FcgammaR. J Biol Chem 2001; 276:6591 - 6604
   PubMed Web of Science ®Google Scholar
• Riesenberg R, Buchner A, Pohla H, Lindhofer H. Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3). J Histochem Cytochem 2001; 49:911 - 917
   PubMed Web of Science ®Google Scholar
• Shen J, Zhu Z. Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer. Curr Opin Mol Ther 2008; 10:273 - 284
   PubMed Web of Science ®Google Scholar
• Sebastian M, Kuemmel A, Schmidt M, Schmittel A. Catumaxomab: a bispecific trifunctional antibody. Drugs Today 2009; 45:589 - 597
   PubMed Web of Science ®Google Scholar
• Parsons S, Murawa PX, Koralewski P, Kutarska E, Kolesnik OO, Stroehlein MA, et al. Intraperitoneal treatment of malignant ascites due to epithelial tumors with catumaxomab: A phase II/III study. J Clin Oncol 2008; 26:3000
   Google Scholar
• Parsons S, Hennig M, Linke R, Klein A, Lahr AS, Lindhofer H, et al. Clinical benefit of catumaxomab in malignant ascites in patient subpopulations in a pivotal phase II/III trial. J Clin Oncol 2009; 27:14000
   Google Scholar
• ICH Q6B “Test procedures and acceptance criteria for biotechnological/biological products” (CPMP/ICH/365/96) http://www.ema.europa.eu/pdfs/human/ich/036596en.pdf.
   Google Scholar
• EMEA “Guideline on development, production, characterization and specifications for monoclonal antibodies and related products” (CHMP/BWP/157653/2007) http://www.ema.europa.eu/pdfs/human/bwp/15765307enfin.pdf.
   Google Scholar
• Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science 1989; 246:64 - 71
   PubMed Web of Science ®Google Scholar
• Verentchikov AN, Ens W, Standing KG. Reflecting time-of-flight mass spectrometer with an electrospray ion source and orthogonal extraction. Anal Chem 1994; 66:126 - 133
   PubMed Web of Science ®Google Scholar
• Dillon TM, Bondarenko PV, Speed Ricci M. Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies. J Chromatogr A 2004; 1053:299 - 305
   PubMed Web of Science ®Google Scholar
• Bondarenko PV, Second TP, Zabrouskov V, Makarov AA, Zhang Z. Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer. J Am Soc Mass Spectrom 2009; 20:1415 - 424
   PubMed Web of Science ®Google Scholar
• Henzel WJ, Stults JT, Hsu CA, Aswad DW. The primary structure of a protein carboxyl methyltransferase from bovine brain that selectively methylates L-isoaspartyl sites. J Biol Chem 1989; 264:15905 - 15911
   PubMed Web of Science ®Google Scholar
• Stults JT. Peptide sequencing by mass spectrometry. Methods Biochem Anal 1990; 34:145 - 201
   PubMedGoogle Scholar
• Chloupek RC, Harris RJ, Leonard CK, Keck RG, Keyt BA, Spellman MW, et al. Study of the primary structure of recombinant tissue plasminogen activator by reversed-phase high-performance liquid chromatographic tryptic mapping. J Chromatogr 1989; 463:375 - 396
   PubMed Web of Science ®Google Scholar
• Ling V, Guzzetta AW, Canova-Davis E, Stults JT, Hancock WS, Covey TR, et al. Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal Chem 1991; 63:2909 - 2915
   PubMed Web of Science ®Google Scholar
• Timm V, Gruber P, Wasiliu M, Lindhofer H, Chelius D. Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. J Chromatogr B 2010; In press
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation. Science 2006; 313:670 - 673
   PubMed Web of Science ®Google Scholar
• Scanlan CN, Burton DR, Dwek RA. Making autoantibodies safe. Proc Natl Acad Sci USA 2008; 105:4081 - 4082
   PubMed Web of Science ®Google Scholar
• Jefferis R. Antibody therapeutics: isotype and glycoform selection. Expert Opin Biol Ther 2007; 7:1401 - 1413
   PubMed Web of Science ®Google Scholar
• Hardy MR, Townsend RR. Separation of positional isomers of oligosaccharides and glycopeptides by high-performance anion-exchange chromatography with pulsed amperometric detection. Proc Natl Acad Sci USA 1988; 85:3289 - 3293
   PubMed Web of Science ®Google Scholar
• Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 1996; 240:210 - 226
   PubMed Web of Science ®Google Scholar
• Guttman A, Chen FT, Evangelista RA, Cooke N. High-resolution capillary gel electrophoresis of reducing oligosaccharides labeled with 1-aminopyrene-3,6,8-trisulfonate. Anal Biochem 1996; 233:234 - 242
   PubMed Web of Science ®Google Scholar
• Tomiya N, Kurono M, Ishihara H, Tejima S, Endo S, Arata Y, et al. Structural analysis of N-linked oligosaccharides by a combination of glycopeptidase, exoglycosidases, and high-performance liquid chromatography. Anal Biochem 1987; 163:489 - 499
   PubMed Web of Science ®Google Scholar
• Townsend RR, Manzi A, Merkle RK, Rohde MF, Spellman M, Smith A, et al. Quantitative Monosaccharide Analysis: A Multi-Center Study ABRF. News 1997; 8
   Google Scholar
• Siemiatkoski J, Lyubarskaya Y, Houde D, Tep S, Mhatre R. A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies. Carbohydr Res 2006; 341:410 - 419
   PubMed Web of Science ®Google Scholar
• Viseux N, Hronowski X, Delaney J, Domon B. Qualitative and quantitative analysis of the glycosylation pattern of recombinant proteins. Anal Chem 2001; 73:4755 - 4762
   PubMed Web of Science ®Google Scholar
• Field M, Papac D, Jones A. The use of high-performance anion-exchange chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to monitor and identify oligosaccharide degradation. Anal Biochem 1996; 239:92 - 98
   PubMed Web of Science ®Google Scholar
• Papac DI, Briggs JB, Chin ET, Jones AJ. A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Glycobiology 1998; 8:445 - 454
   PubMed Web of Science ®Google Scholar
• Harvey DJ. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003–2004. Mass Spectrom Rev 2009; 28:273 - 361
   PubMed Web of Science ®Google Scholar
• Thaysen-Andersen M, Mysling S, Højrup P. Site-specific glycoprofiling of N-linked glycopeptides using MALDI-TOF MS: strong correlation between signal strength and glycoform quantities. Anal Chem 2009; 81:3933 - 3943
   PubMed Web of Science ®Google Scholar
• Sinha S, Pipes G, Topp EM, Bondarenko PV, Treuheit MJ, Gadgil HS. Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs. J Am Soc Mass Spectrom 2008; 19:1643 - 1654
   PubMed Web of Science ®Google Scholar
• Sreerama N, Woody RW. Computation and analysis of protein circular dichroism spectra. Methods Enzymol 2004; 383:318 - 351
   PubMed Web of Science ®Google Scholar
• Greenfield NJ. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 2006; 1:2876 - 2890
   PubMed Web of Science ®Google Scholar
• Holzwarth G, Doty P. The ultraviolet circular dichroism of polypeptides. J Am Chem Soc 1965; 87:218 - 228
   PubMed Web of Science ®Google Scholar
• Greenfield N, Fasman GD. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 1969; 8:4108 - 4116
   PubMed Web of Science ®Google Scholar
• Venyaminov S, Baikalov IA, Shen ZM, Wu CS, Yang JT. Circular dichroic analysis of denatured proteins: inclusion of denatured proteins in the reference set. Anal Biochem 1993; 214:17 - 24
   PubMed Web of Science ®Google Scholar
• Eftink MR. Fluorescence techniques for studying protein structure. Methods Biochem Anal 1991; 35:127 - 205
   PubMedGoogle Scholar
• Vivian JT, Callis PR. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J 2001; 80:2093 - 2109
   PubMed Web of Science ®Google Scholar
• Frey S, Haslbeck M, Hainzl O, Buchner J. Synthesis and characterization of a functional intact IgG in a prokaryotic cell-free expression system. Biol Chem 2008; 389:37 - 45
   PubMed Web of Science ®Google Scholar
• Böhm G, Muhr R, Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng 1992; 5:191 - 195
   PubMedGoogle Scholar
• Tetin SY, Prendergast FG, Venyaminov SY. Accuracy of protein secondary structure determination from circular dichroism spectra based on immunoglobulin examples. Anal Biochem 2003; 321:183 - 187
   PubMed Web of Science ®Google Scholar
• Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, et al. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 2001; 293:1155 - 1159
   PubMed Web of Science ®Google Scholar
• Ruf P, Gires O, Jäger M, Fellinger K, Atz J, Lindhofer H. Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer. Br J Cancer 2007; 97:315 - 321
   PubMed Web of Science ®Google Scholar
• Jäager M, Schoberth A, Ruf P, Hess J, Lindhofer H. The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2. Cancer Res 2009; 69:4270 - 4276
   PubMed Web of Science ®Google Scholar
• Stanglmaier M, Faltin M, Ruf P, Bodenhausen A, Schröder P, Lindhofer H. Bi20 (FBTA05), a novel trifunctional bispecific antibody (anti-CD20 × anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels. Int J Cancer 2008; 123:1181 - 1189
   PubMed Web of Science ®Google Scholar
• Pekar A, Sukumar M. Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation: practical considerations that affect precision and accuracy. Anal Biochem 2007; 367:225 - 237
   PubMed Web of Science ®Google Scholar
• Gabrielson JP, Brader ML, Pekar AH, Mathis KB, Winter G, Carpenter JF, et al. Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. J Pharm Sci 2007; 96:268 - 279
   PubMed Web of Science ®Google Scholar
• Arakawa T, Philo JS, Ejima D, Tsumoto K, Arisaka F. Aggregation analysis of therapeutic proteins, part 1: General aspects and techniques for assessment. Bioprocess International 2006; 4:42 - 49
   Google Scholar
• Arakawa T, Philo JS, Ejima D, Tsumoto K, Arisaka F. Aggregation analysis of therapeutic proteins, part 2: Analytical ultracentrifugation and dynamic light scattering. Bioprocess International 2007; 5:36 - 47
   Google Scholar
• Svedberg T, Pedersen KO. The Ultracentrifuge 1940; Oxford Clarendon Press
   Google Scholar
• Philo JS. Schuster TM, Laue TM. Measuring sedimentation, diffusion and molecular weights of small molecules by direct fitting of sedimentation velocity concentration profiles. Modern Analytical Ultracentrifugation 1994; Boston Birkhauser 156 - 170
   Google Scholar
• Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys J 2000; 78:1606 - 1619
   PubMed Web of Science ®Google Scholar
• Wahlund KG, Litzén A. Application of an asymmetrical flow field-flow fractionation channel to the separation and characterization of proteins, plasmids, plasmid fragments, polysaccharides and unicellular algae. J Chromatogr 1989; 6:73 - 87
   Web of Science ®Google Scholar
• Liu MK, Li P, Giddings JC. Rapid protein separation and diffusion coefficient measurement by frit inlet flow field-flow fractionation. Protein Sci 1993; 2:1520 - 1531
   PubMed Web of Science ®Google Scholar
• Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl 2001; 752:233 - 245
   PubMed Web of Science ®Google Scholar
• Chu GC, Chelius D, Xiao G, Khor HK, Coulibaly S, Bondarenko PV. Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures. Pharm Res 2007; 24:1145 - 1156
   Google Scholar
• Perkins M, Theiler R, Lunte S, Jeschke M. Determination of the origin of charge heterogeneity in a murine monoclonal antibody. Pharm Res 2000; 17:1110 - 1117
   PubMed Web of Science ®Google Scholar
• Zhang W, Czupryn MJ. Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms. J Pharm Biomed Anal 2003; 30:1479 - 1490
   PubMed Web of Science ®Google Scholar
• Dick LW Jr, Qiu D, Cheng KC. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:3841 - 3849
   PubMed Web of Science ®Google Scholar
• Dillon TM, Bondarenko PV, Rehder DS, Pipes GD, Kleemann GR, Ricci MS. Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. J Chromatogr A 2006; 1120:112 - 120
   PubMed Web of Science ®Google Scholar
• Ren D, Pipes GD, Hambly DM, Bondarenko PV, Treuheit MJ, Brems DN, et al. Reversed-phase liquid chromatography of immunoglobulin G molecules and their fragments with the diphenyl column. J Chromatogr A 2007; 1175:63 - 68
   PubMed Web of Science ®Google Scholar
• Ren D, Pipes G, Xiao G, Kleemann GR, Bondarenko PV, Treuheit MJ, Gadgil HS. Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments. J Chromatogr A 2008; 1179:198 - 204
   PubMed Web of Science ®Google Scholar
• Gangopadhyay A, Saravis CA, van den Abbeele AD, Kassis AI. pI-dependent isolation of antibody isoforms by semipreparative isoelectric focusing. Q J Nucl Med 1995; 39:129 - 133
   PubMedGoogle Scholar
• Vlasak J, Ionescu R. Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. Curr Pharm Biotechnol 2008; 9:468 - 481
   PubMed Web of Science ®Google Scholar
• Lam XM, Yang JY, Cleland JL. Antioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2. J Pharm Sci 1997; 86:1250 - 1255
   PubMed Web of Science ®Google Scholar
• Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci 2009; 18:424 - 433
   PubMed Web of Science ®Google Scholar
• Liu D, Ren D, Huang H, Dankberg J, Rosenfeld R, Cocco MJ, et al. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. Biochemistry 2008; 47:5088 - 5100
   PubMed Web of Science ®Google Scholar
• Chelius D, Rehder DS, Bondarenko PV. Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. Anal Chem 2005; 77:6004 - 6011
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Chumsae C. Glutamine deamidation of a recombinant monoclonal antibody. Rapid Commun Mass Spectrom 2008; 22:4081 - 4088
   PubMed Web of Science ®Google Scholar
• Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 2009; 392:145 - 154
   PubMed Web of Science ®Google Scholar
• Rehder DS, Chelius D, McAuley A, Dillon TM, Xiao G, Crouse-Zeineddini J, et al. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. Biochemistry 2008; 47:2518 - 2530
   PubMed Web of Science ®Google Scholar
• Wakankar AA, Borchardt RT, Eigenbrot C, Shia S, Wang YJ, Shire SJ, et al. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. Biochemistry 2007; 46:1534 - 1544
   PubMed Web of Science ®Google Scholar
• Chelius D, Jing K, Lueras A, Rehder DS, Dillon TM, Vizel A, et al. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem 2006; 78:2370 - 2376
   PubMed Web of Science ®Google Scholar
• Rehder DS, Dillon TM, Pipes GD, Bondarenko PV. Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. J Chromatogr A 2006; 1102:164 - 175
   PubMed Web of Science ®Google Scholar
• Dick LW Jr, Qiu D, Mahon D, Adamo M, Cheng KC. C-terminal lysine variants in fully human monoclonal antibodies: investigation of test methods and possible causes. Biotechnol Bioeng 2008; 100:1132 - 1143
   PubMed Web of Science ®Google Scholar
• Pristatsky P, Cohen SL, Krantz D, Acevedo J, Ionescu R, Vlasak J. Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody. Anal Chem 2009; 81:6148 - 6155
   PubMed Web of Science ®Google Scholar
• Dillon TM, Ricci MS, Vezina C, Flynn GC, Liu YD, Rehder DS, et al. Structural and functional characterization of disulfide isoforms of the human IgG2 subclass. J Biol Chem 2008; 283:16206 - 16215
   PubMed Web of Science ®Google Scholar
• Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, et al. Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem 2008; 283:16194 - 16205
   PubMed Web of Science ®Google Scholar